查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1588499

蛋白質表現市場規模、佔有率、成長分析、按產品和服務、按系統類型、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Protein Expression Market Size, Share, Growth Analysis, By Product and Service, By System Type, By Application, By End User, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 209 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球蛋白表現市場規模為29億美元，從2023年的32.9億美元成長到2031年的89.2億美元，預計複合年成長率為13.3%。

由於生物技術進步推動治療應用重組蛋白的需求不斷增加，蛋白表現市場正經歷快速成長。個人化醫療的興起進一步加速了對客製化蛋白質療法的需求。蛋白質工程和重組蛋白人工生產的持續研究和開發正在推動市場進步。此外，蛋白質表現的創新為透過個人化治療改善患者護理提供了新的機會。透過與市場參與者和學術機構的策略聯盟，促進桿狀病毒和瞬時表達系統等最尖端科技的開發，從而促進市場擴張。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 二手資料來源和主要資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 價格分析
  • 技術分析
  • 專利分析
  • 價值鏈分析
  • 供應鏈分析
  • 客戶和購買標準分析
  • 監管分析

蛋白質表現市場：依產品/服務分類

  • 市場概況
  • 試劑
  • 表達載體
  • 勝任細胞
  • 裝置
  • 服務

蛋白質表現市場：依系統類型

  • 市場概況
  • 哺乳動物細胞表現系統
    • 中國倉鼠卵巢細胞系統（Cho細胞系統）
    • 人類胎兒腎細胞系統（Hek 293細胞系統）
    • 其他哺乳動物細胞株
  • 原核表達系統
    • 大腸桿菌系統
    • 其他原核表達系統
  • 昆蟲細胞表現系統
    • 桿狀病毒系統
    • 其他昆蟲細胞系統
  • 酵母表現系統
    • 畢赤酵母系統
    • 酵母系統
    • 其他酵母表現系統
  • 無細胞表現系統
  • 基於藻類的表達系統

蛋白質表現市場：依應用分類

  • 市場概況
  • 治療用途
  • 研究用途
  • 工業用途

蛋白質表現市場：依最終用戶分類

  • 市場概況
  • 製藥和生物技術公司
  • 學術研究所
  • 受託研究機構以及合約開發和製造組織（CROS 和 CDMO）
  • 其他最終用戶

蛋白質表現市場：按地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位（2023年）
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率（2023年）

主要企業簡介

  • Thermo Fisher Scientific, Inc.（US）
  • Merck KGaA（Germany）
  • Genscript Biotech Corporation（China）
  • Agilent Technologies Inc.（US）
  • Takara Bio, Inc.（Japan）
  • Bio-Rad Laboratories, Inc.（US）
  • Qiagen NV（Netherlands）
  • Charles River Laboratories International, Inc.（US）
  • Danaher Corporation（US）
  • Sartorius AG（Germany）
  • Corning Incorporated（US）
  • Fujifilm Irvine Scientific, Inc.（Acquired by Fujifilm Holdings Corporation）（US）
  • Lonza Group AG（Switzerland）
  • Bioneer Corporation（South Korea）
  • Promega Corporation（US）
  • Oxford Expression Technologies Ltd.（UK）
  • Proteogenix（France）
  • Abeomics Inc.（US）
  • New England Biolabs, Inc.（US）
  • Promab Biotechnologies（US）
  • Sino Biological, Inc.（China）
  • Jena Bioscience（Germany）
  • Lifesensors, Inc.（US）
  • Leading Biology, Inc.（US）
  • Peak Proteins（UK）
簡介目錄
Product Code: SQMIG35H2291

Global Protein Expression Market size was valued at USD 2.90 billion in 2022 and is poised to grow from USD 3.29 billion in 2023 to USD 8.92 billion by 2031, growing at a CAGR of 13.3% in the forecast period (2024-2031).

The protein expression market is experiencing rapid growth due to the increasing demand for recombinant proteins in therapeutic applications, fueled by advancements in biotechnology. The rise of personalized medicine has further accelerated the need for customized protein-based therapies. Ongoing research and development in protein engineering and the artificial production of recombinant proteins are driving market progress. Additionally, technological innovations in protein expression are opening new opportunities to improve patient care through personalized treatments. Strategic collaborations between market players and academic institutions are fostering the development of cutting-edge technologies, including baculovirus and transient expression systems, boosting market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Protein Expression market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Protein Expression Market Segmental Analysis

Global Protein Expression Market is segmented on the product & service, system type, application, end user, and region. By product and service, the market is segmented into Reagents, Expression Vectors, Competent Cells, Instruments, and Services. By system type, the market is segmented into Mammalian Cell Expression Systems, Prokaryotic Expression Systems, Insect Cell Expression Systems, Yeast Expression Systems, Cell-Free Expression Systems, and Algal-Based Expression Systems. By application, the market is segmented into Therapeutic Applications, Research Applications, and Industrial Applications. By end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations & Contract Development and Manufacturing Organizations (CROs & CDMOs), and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Protein Expression Market

The protein expression market is experiencing significant growth, driven by the widespread use of E. coli bacteria for large-scale protein manufacturing. E. coli is the most commonly used expression host due to its well-established genomic and sequencing systems, which streamline cloning processes. This makes E. coli the preferred choice in the pharmaceutical sector for protein expression. Additionally, this method enhances the strength of binding in the promoter region, optimizing transcription and further boosting its adoption. These factors collectively contribute to the rapid expansion of the protein expression market.

Restraints in the Global Protein Expression Market

The Protein Expression market faces significant barriers to entry, particularly for new organizations. High costs associated with protein expression reagents and products are inhibiting market growth, while limited awareness of relevant diseases further discourages investment. This issue is especially prominent in developing countries and for smaller companies with constrained budgets. Additionally, the lack of supportive insurance systems in emerging economies is restricting the adoption of advanced eukaryotic expression system products. These challenges are hindering the market's expansion and preventing many potential players from entering the space.

Market Trends of the Global Protein Expression Market

The Protein Expression market is experiencing significant growth driven by the rising demand for biologics used in treating chronic diseases such as cancer, autoimmune disorders, and other serious conditions. Biologics, which include vaccines, blood components, modified medicinal proteins, antibodies, pegylated proteins, hormones, and enzymes, are essential in protein translation. As these biologic therapies continue to expand in demand, the need for protein expression products and services is growing, further propelling the market's development. This trend highlights the crucial role of protein translation in the creation and delivery of innovative biologic treatments.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Value Chain Analysis
  • Supply Chain Analysis
  • Customer & Buying Criteria Analysis
  • Regulatory Analysis

Protein Expression Market, By Product & Service

  • Market Overview
  • Reagents
  • Expression Vectors
  • Competent Cells
  • Instruments
  • Services

Protein Expression Market, By System Type

  • Market Overview
  • Mammalian Cell Expression Systems
    • Chinese Hamster Ovary Cell Systems (Cho Cell Systems)
    • Human Embryonic Kidney Cell Systems (Hek 293 Cell Systems)
    • Other Mammalian Cell Systems
  • Prokaryotic Expression Systems
    • Escherichia Coli Systems
    • Other Prokaryotic Expression Systems
  • Insect Cell Expression Systems
    • Baculovirus Systems
    • Other Insect Cell Systems
  • Yeast Expression Systems
    • Pichia Systems
    • Saccharomyces Systems
    • Other Yeast Expression Systems
  • Cell-Free Expression Systems
  • Algal-Based Expression Systems

Protein Expression Market, By Application

  • Market Overview
  • Therapeutic Applications
  • Research Applications
  • Industrial Applications

Protein Expression Market, By End User

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations & Contract Development & Manufacturing Organizations (CROS & CDMOs)
  • Other End Users

Protein Expression Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Thermo Fisher Scientific, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genscript Biotech Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Irvine Scientific, Inc. (Acquired by Fujifilm Holdings Corporation) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioneer Corporation (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Expression Technologies Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteogenix (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abeomics Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New England Biolabs, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promab Biotechnologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sino Biological, Inc. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jena Bioscience (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifesensors, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leading Biology, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Peak Proteins (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments